Currently, there are 650.70M common shares owned by the public and among those 616.34M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -7.77% and -8.75% over the past three months. DVN shares are trading 5.13% year to date (YTD), with the 12-month market performance down to -20.83% lower. It has a 12-month low price of $30.39 and touched a high of $54.63 over the same period. DVN has an average intraday trading volume of 10.42 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -2.35%, -0.79%, and -15.52% respectively.
Institutional ownership of Devon Energy Corp (NYSE: DVN) shares accounts for 73.51% of the company’s 650.70M shares outstanding.
It has a market capitalization of $22.33B and a beta (3y monthly) value of 1.95. The stock’s trailing 12-month PE ratio is 7.53, while the earnings-per-share (ttm) stands at $4.57. The company has a PEG of 1.40 and a Quick Ratio of 0.95 with the debt-to-equity ratio at 0.64. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.34% over the week and 3.50% over the month.
Earnings per share for the fiscal year are expected to decrease by -1.42%, and 11.00% over the next financial year.
Looking at the support for the DVN, a number of firms have released research notes about the stock. Bernstein stated their Outperform rating for the stock in a research note on January 15, 2025, with the firm’s price target at $45. The Benchmark Company coverage for the Devon Energy Corp (DVN) stock in a research note released on January 14, 2025 offered a Buy rating with a price target of $44. Wolfe Research was of a view on January 03, 2025 that the stock is Outperform, while JP Morgan gave the stock Neutral rating on December 05, 2024, issuing a price target of $43. Truist on their part issued Hold rating on November 07, 2024.
